Industry Research Reports

Home > Reports > Medical Care > Global and China Human Oocyte Cryopreservation Market Report & Forecast 2024-2030

Global and China Human Oocyte Cryopreservation Market Report & Forecast 2024-2030

Industry: Medical Care

Published: 2024-11-29

Pages: 123 Pages

Report ld: 3389852

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Human Oocyte Cryopreservation revenue was US$ 82 million in 2023 and is forecast to a readjusted size of US$ 210 million by 2030 with a CAGR of 15.0% during the review period (2024-2030).

In China the Human Oocyte Cryopreservation revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

Human Oocyte Cryopreservation Market Size

M= millions and B=billions

This report focuses on global and China Human Oocyte Cryopreservation market, also covers the segmentation data of other regions in regional level and county level.

Human oocyte cryopreservation (egg freezing) is a procedure to preserve female eggs (oocytes). The eggs are extracted, frozen and stored. The purpose of the procedure is to give women the option of thawing, fertilizing and transplanting the eggs into the uterus as embryos to promote future pregnancy.

Oocyte cryopreservation refers to the technology of cooling human oocytes and storing them in liquid nitrogen (generally stored in liquid nitrogen at -196°C), resuscitating (thawing) them when needed, and ensuring that the oocytes are alive and functioning normally. It is a derivative technology of assisted reproductive technology, mainly used to treat infertility and preserve female fertility.

The driving factors of the oocyte cryopreservation market mainly include the following aspects:
Technological progress
The continuous improvement and maturity of oocyte cryopreservation technology has improved the recovery rate and survival rate of frozen oocytes, thereby increasing the clinical application prospects of this technology and driving the development of the market.

Changes in fertility concepts
The changes in modern women's fertility concepts and the intensification of the trend of late marriage and late childbearing have led more and more women to choose oocyte cryopreservation technology to maintain fertility and provide guarantees for future fertility plans.

Growth in medical demand
With the improvement of medical standards and people's attention to reproductive health, more and more medical institutions and patients have begun to pay attention to oocyte cryopreservation technology, which has promoted the rapid development of the market.

Policy support
The support policies of some countries and regions for assisted reproductive technology, as well as the improvement of relevant laws and regulations, have provided a good policy environment for the development of oocyte cryopreservation technology.

Unlike sperm, oocytes are larger and contain a lot of water, which makes it easier to form ice crystals that may damage the eggs during the freezing process. In addition, egg extraction is not easy and the number is scarce, so the selection of protective agents during the freezing process is also more demanding. These factors have made egg freezing one of the difficulties in freezing technology.

However, with the continuous advancement of technology, the success rate of oocyte cryopreservation has been significantly improved. International clinical trials have proven that frozen eggs can be stored for at least ten years, and they still have the ability to conceive after thawing, can form healthy embryos, and can normally conceive babies. This has led more and more women to choose to preserve their future reproductive ability through oocyte cryopreservation technology, that is, to buy a "fertility insurance".

In general, oocyte cryopreservation technology provides an effective option for women who want to preserve their fertility, and also provides new possibilities for the development of assisted reproductive technology.

Global Human Oocyte Cryopreservation Scope and Market Size
Human Oocyte Cryopreservation market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Oocyte Cryopreservation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2019-2030.

For China market, this report focuses on the Human Oocyte Cryopreservation market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in China.

Market Segmentation

Report Metric
Details
Report Title
Global and China Human Oocyte Cryopreservation Market Report & Forecast 2024-2030
Forecasted Market Size in 2030
US$ 210 million
CAGR(2024-2030)
15%
Market Size Available for Years
2019-2030
Global Human Oocyte Cryopreservation Companies Covered
Anova Fertility, CCRM IVF, Chill, CREATE Fertility, Extend Fertility, HRC Fertility, IVF Australia, Kindbody, London Women’s Clinic, Manchester Fertility, Mayo Clinic, Melbourne IVF, Monash IVF, Pacific Fertility Center-Los Angeles (PFCLA), PIVET, Prelude Fertility
Global Human Oocyte Cryopreservation Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Oocyte Cryopreservation Market, Segment by Type
Slow-cooling Method

Flash-freezing Process (Vitrification)
Global Human Oocyte Cryopreservation Market, Segment by Application
25-30 Year Old Female

30-35 Year Old Female

35-40 Year Old Female

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces Human Oocyte Cryopreservation definition, global market size, China market size, China percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Human Oocyte Cryopreservation companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue of Human Oocyte Cryopreservation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6: Americas by Type, by Application and by country, revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Oocyte Cryopreservation revenue, gross margin, and recent development, etc.
Chapter 11: Analyst's Viewpoints/Conclusion

Table of Contents

 1 Study Coverage
    1.1 Human Oocyte Cryopreservation Product Introduction
    1.2 Global Human Oocyte Cryopreservation Outlook, 2019 VS 2023 VS 2030
        1.2.1 Global Human Oocyte Cryopreservation Market Size for the Year 2019-2030
        1.2.2 China Human Oocyte Cryopreservation Market Size for the Year 2019-2030
    1.3 Human Oocyte Cryopreservation Market Size, China VS Global, 2019 VS 2023 VS 2030
        1.3.1 The Market Share of China Human Oocyte Cryopreservation in Global, 2019 VS 2023 VS 2030
        1.3.2 The Growth Rate of Human Oocyte Cryopreservation Market Size, China VS Global, 2019 VS 2023 VS 2030
    1.4 Human Oocyte Cryopreservation Market Dynamics
        1.4.1 Human Oocyte Cryopreservation Industry Trends
        1.4.2 Human Oocyte Cryopreservation Market Drivers
        1.4.3 Human Oocyte Cryopreservation Market Challenges
        1.4.4 Human Oocyte Cryopreservation Market Restraints
    1.5 Assumptions and Limitations
    1.6 Study Objectives
    1.7 Years Considered

 2 Human Oocyte Cryopreservation by Type
    2.1 Human Oocyte Cryopreservation Market by Type
        2.1.1 Slow-cooling Method
        2.1.2 Flash-freezing Process (Vitrification)
    2.2 Global Human Oocyte Cryopreservation Market Size by Type (2019, 2023 & 2030)
    2.3 Global Human Oocyte Cryopreservation Market Size by Type (2019-2030)
    2.4 China Human Oocyte Cryopreservation Market Size by Type (2019, 2023 & 2030)
    2.5 China Human Oocyte Cryopreservation Market Size by Type (2019-2030)

 3 Human Oocyte Cryopreservation by Application
    3.1 Human Oocyte Cryopreservation Market by Application
        3.1.1 25-30 Year Old Female
        3.1.2 30-35 Year Old Female
        3.1.3 35-40 Year Old Female
        3.1.4 Others
    3.2 Global Human Oocyte Cryopreservation Market Size, by Application (2019, 2023 & 2030)
    3.3 Global Human Oocyte Cryopreservation Market Size by Application (2019-2030)
    3.4 China Human Oocyte Cryopreservation Market Size by Application (2019, 2023 & 2030)
    3.5 China Human Oocyte Cryopreservation Market Size by Application (2019-2030)

 4 Global Human Oocyte Cryopreservation Competitor Landscape by Company
    4.1 Global Human Oocyte Cryopreservation Market Size by Company
        4.1.1 Global Key Companies of Human Oocyte Cryopreservation, Ranked by Revenue (2023)
        4.1.2 Global Human Oocyte Cryopreservation Revenue by Player (2019-2024)
    4.2 Global Human Oocyte Cryopreservation Concentration Ratio (CR)
        4.2.1 Human Oocyte Cryopreservation Market Concentration Ratio (CR) (2019-2024)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Human Oocyte Cryopreservation in 2023
        4.2.3 Global Human Oocyte Cryopreservation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Key Players of Human Oocyte Cryopreservation Head office and Area Served
    4.4 Global Key Players of Human Oocyte Cryopreservation, Product and Application
    4.5 Global Key Players of Human Oocyte Cryopreservation, Date of Enter into This Industry
    4.6 Companies Mergers & Acquisitions, Expansion Plans
    4.7 China Human Oocyte Cryopreservation Market Size by Company
        4.7.1 Key Players of Human Oocyte Cryopreservation in China, Ranked by Revenue (2023)
        4.7.2 China Human Oocyte Cryopreservation Revenue by Players (2022, 2023 & 2024)

 5 Global Human Oocyte Cryopreservation Market Size by Region
    5.1 Global Human Oocyte Cryopreservation Market Size by Region: 2019 VS 2023 VS 2030
    5.2 Global Human Oocyte Cryopreservation Market Size by Region (2019-2030)
        5.2.1 Global Human Oocyte Cryopreservation Market Size by Region: 2019-2024
        5.2.2 Global Human Oocyte Cryopreservation Market Size by Region: 2025-2030

 6 Americas
    6.1 Americas Human Oocyte Cryopreservation Market Size YoY Growth 2019-2030
    6.2 Americas Human Oocyte Cryopreservation Market Size by Type
        6.2.1 Americas Human Oocyte Cryopreservation Market Size by Type (2019-2024)
        6.2.2 Americas Human Oocyte Cryopreservation Market Size by Type (2025-2030)
        6.2.3 Americas Human Oocyte Cryopreservation Market Share by Type (2019-2030)
    6.3 Americas Human Oocyte Cryopreservation Market Size by Application
        6.3.1 Americas Human Oocyte Cryopreservation Market Size by Application (2019-2024)
        6.3.2 Americas Human Oocyte Cryopreservation Market Size by Application (2025-2030)
        6.3.3 Americas Human Oocyte Cryopreservation Market Share by Application (2019-2030)
    6.4 Americas Human Oocyte Cryopreservation Market Facts & Figures by Country (2019, 2023 & 2030)
        6.4.1 United States
        6.4.2 Canada
        6.4.3 Mexico
        6.4.4 Brazil

 7 EMEA
    7.1 EMEA Human Oocyte Cryopreservation Market Size YoY Growth 2019-2030
    7.2 EMEA Human Oocyte Cryopreservation Market Size by Type
        7.2.1 EMEA Human Oocyte Cryopreservation Market Size by Type (2019-2024)
        7.2.2 EMEA Human Oocyte Cryopreservation Market Size by Type (2025-2030)
        7.2.3 EMEA Human Oocyte Cryopreservation Market Share by Type (2019-2030)
    7.3 EMEA Human Oocyte Cryopreservation Market Size by Application
        7.3.1 EMEA Human Oocyte Cryopreservation Market Size by Application (2019-2024)
        7.3.2 EMEA Human Oocyte Cryopreservation Market Size by Application (2025-2030)
        7.3.3 EMEA Human Oocyte Cryopreservation Market Share by Application (2019-2030)
    7.4 EMEA Human Oocyte Cryopreservation Market Facts & Figures by Region (2019, 2023 & 2030)
        7.4.1 Europe
        7.4.2 Middle East
        7.4.3 Africa

 8 China
    8.1 China Human Oocyte Cryopreservation Market Size by Type
        8.1.1 China Human Oocyte Cryopreservation Market Size by Type (2019-2024)
        8.1.2 China Human Oocyte Cryopreservation Market Size by Type (2025-2030)
        8.1.3 China Human Oocyte Cryopreservation Market Share by Type (2019-2030)
    8.2 China Human Oocyte Cryopreservation Market Size by Application
        8.2.1 China Human Oocyte Cryopreservation Market Size by Application (2019-2024)
        8.2.2 China Human Oocyte Cryopreservation Market Size by Application (2025-2030)
        8.2.3 China Human Oocyte Cryopreservation Market Share by Application (2019-2030)

 9 APAC (excluding China)
    9.1 APAC Human Oocyte Cryopreservation Market Size YoY Growth 2019-2030
    9.2 APAC Human Oocyte Cryopreservation Market Size by Type
        9.2.1 APAC Human Oocyte Cryopreservation Market Size by Type (2019-2024)
        9.2.2 APAC Human Oocyte Cryopreservation Market Size by Type (2025-2030)
        9.2.3 APAC Human Oocyte Cryopreservation Market Share by Type (2019-2030)
    9.3 APAC Human Oocyte Cryopreservation Market Size by Application
        9.3.1 APAC Human Oocyte Cryopreservation Market Size by Application (2019-2024)
        9.3.2 APAC Human Oocyte Cryopreservation Market Size by Application (2025-2030)
        9.3.3 APAC Human Oocyte Cryopreservation Market Share by Application (2019-2030)
    9.4 APAC Human Oocyte Cryopreservation Market Facts & Figures by Region (2019, 2023 & 2030)
        9.4.1 Japan
        9.4.2 South Korea
        9.4.3 China Taiwan
        9.4.4 ASEAN
        9.4.5 India

 10 Key Players Profiles
    10.1 Anova Fertility
        10.1.1 Anova Fertility Company Details
        10.1.2 Anova Fertility Business Overview
        10.1.3 Anova Fertility Human Oocyte Cryopreservation Introduction
        10.1.4 Anova Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.1.5 Anova Fertility Recent Development
    10.2 CCRM IVF
        10.2.1 CCRM IVF Company Details
        10.2.2 CCRM IVF Business Overview
        10.2.3 CCRM IVF Human Oocyte Cryopreservation Introduction
        10.2.4 CCRM IVF Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.2.5 CCRM IVF Recent Development
    10.3 Chill
        10.3.1 Chill Company Details
        10.3.2 Chill Business Overview
        10.3.3 Chill Human Oocyte Cryopreservation Introduction
        10.3.4 Chill Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.3.5 Chill Recent Development
    10.4 CREATE Fertility
        10.4.1 CREATE Fertility Company Details
        10.4.2 CREATE Fertility Business Overview
        10.4.3 CREATE Fertility Human Oocyte Cryopreservation Introduction
        10.4.4 CREATE Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.4.5 CREATE Fertility Recent Development
    10.5 Extend Fertility
        10.5.1 Extend Fertility Company Details
        10.5.2 Extend Fertility Business Overview
        10.5.3 Extend Fertility Human Oocyte Cryopreservation Introduction
        10.5.4 Extend Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.5.5 Extend Fertility Recent Development
    10.6 HRC Fertility
        10.6.1 HRC Fertility Company Details
        10.6.2 HRC Fertility Business Overview
        10.6.3 HRC Fertility Human Oocyte Cryopreservation Introduction
        10.6.4 HRC Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.6.5 HRC Fertility Recent Development
    10.7 IVF Australia
        10.7.1 IVF Australia Company Details
        10.7.2 IVF Australia Business Overview
        10.7.3 IVF Australia Human Oocyte Cryopreservation Introduction
        10.7.4 IVF Australia Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.7.5 IVF Australia Recent Development
    10.8 Kindbody
        10.8.1 Kindbody Company Details
        10.8.2 Kindbody Business Overview
        10.8.3 Kindbody Human Oocyte Cryopreservation Introduction
        10.8.4 Kindbody Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.8.5 Kindbody Recent Development
    10.9 London Women’s Clinic
        10.9.1 London Women’s Clinic Company Details
        10.9.2 London Women’s Clinic Business Overview
        10.9.3 London Women’s Clinic Human Oocyte Cryopreservation Introduction
        10.9.4 London Women’s Clinic Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.9.5 London Women’s Clinic Recent Development
    10.10 Manchester Fertility
        10.10.1 Manchester Fertility Company Details
        10.10.2 Manchester Fertility Business Overview
        10.10.3 Manchester Fertility Human Oocyte Cryopreservation Introduction
        10.10.4 Manchester Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.10.5 Manchester Fertility Recent Development
    10.11 Mayo Clinic
        10.11.1 Mayo Clinic Company Details
        10.11.2 Mayo Clinic Business Overview
        10.11.3 Mayo Clinic Human Oocyte Cryopreservation Introduction
        10.11.4 Mayo Clinic Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.11.5 Mayo Clinic Recent Development
    10.12 Melbourne IVF
        10.12.1 Melbourne IVF Company Details
        10.12.2 Melbourne IVF Business Overview
        10.12.3 Melbourne IVF Human Oocyte Cryopreservation Introduction
        10.12.4 Melbourne IVF Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.12.5 Melbourne IVF Recent Development
    10.13 Monash IVF
        10.13.1 Monash IVF Company Details
        10.13.2 Monash IVF Business Overview
        10.13.3 Monash IVF Human Oocyte Cryopreservation Introduction
        10.13.4 Monash IVF Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.13.5 Monash IVF Recent Development
    10.14 Pacific Fertility Center-Los Angeles (PFCLA)
        10.14.1 Pacific Fertility Center-Los Angeles (PFCLA) Company Details
        10.14.2 Pacific Fertility Center-Los Angeles (PFCLA) Business Overview
        10.14.3 Pacific Fertility Center-Los Angeles (PFCLA) Human Oocyte Cryopreservation Introduction
        10.14.4 Pacific Fertility Center-Los Angeles (PFCLA) Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.14.5 Pacific Fertility Center-Los Angeles (PFCLA) Recent Development
    10.15 PIVET
        10.15.1 PIVET Company Details
        10.15.2 PIVET Business Overview
        10.15.3 PIVET Human Oocyte Cryopreservation Introduction
        10.15.4 PIVET Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.15.5 PIVET Recent Development
    10.16 Prelude Fertility
        10.16.1 Prelude Fertility Company Details
        10.16.2 Prelude Fertility Business Overview
        10.16.3 Prelude Fertility Human Oocyte Cryopreservation Introduction
        10.16.4 Prelude Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024)
        10.16.5 Prelude Fertility Recent Development

 11 Research Findings and Conclusion

 12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
            12.1.1.1 Research Programs/Design
            12.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        12.1.2 Data Source
            12.1.2.1 Secondary Sources
            12.1.2.2 Primary Sources
    12.2 Author Details
    12.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Human Oocyte Cryopreservation Market Size, China VS Global, CAGR (2019 VS 2023 VS 2030)
 Table 2. Human Oocyte Cryopreservation Market Trends
 Table 3. Human Oocyte Cryopreservation Market Drivers
 Table 4. Human Oocyte Cryopreservation Market Challenges
 Table 5. Human Oocyte Cryopreservation Market Restraints
 Table 6. Global Human Oocyte Cryopreservation Market Size Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. China Human Oocyte Cryopreservation Market Size by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global Human Oocyte Cryopreservation Market Size Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. China Human Oocyte Cryopreservation Market Size by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 10. Global Key Companies of Human Oocyte Cryopreservation, Ranked by Revenue (2023) & (US$ Million)
 Table 11. Global Human Oocyte Cryopreservation Revenue by Player, (US$ Million), 2019-2024
 Table 12. Global Human Oocyte Cryopreservation Revenue Share by Player, 2019-2024
 Table 13. Global Human Oocyte Cryopreservation Companies Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Oocyte Cryopreservation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Oocyte Cryopreservation as of 2023)
 Table 15. Global Key Players of Human Oocyte Cryopreservation, Headquarters and Area Served
 Table 16. Global Key Players of Human Oocyte Cryopreservation, Product and Application
 Table 17. Global Key Players of Human Oocyte Cryopreservation, Date of Enter into This Industry
 Table 18. Companies Mergers & Acquisitions, Expansion Plans
 Table 19. Key Players of Human Oocyte Cryopreservation in China, Ranked by Revenue (2023) & (US$ Million)
 Table 20. China Human Oocyte Cryopreservation Revenue by Players, (US$ Million), 2022, 2023 & 2024
 Table 21. China Human Oocyte Cryopreservation Revenue Share by Players, 2022, 2023 & 2024
 Table 22. Global Human Oocyte Cryopreservation Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 23. Global Human Oocyte Cryopreservation Market Size by Region (2019-2024) & (US$ Million)
 Table 24. Global Human Oocyte Cryopreservation Market Size Forecast by Region (2025-2030) & (US$ Million)
 Table 25. Americas Human Oocyte Cryopreservation Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Americas Human Oocyte Cryopreservation Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Americas Human Oocyte Cryopreservation Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Americas Human Oocyte Cryopreservation Market Size by Application (2025-2030) & (US$ Million)
 Table 29. Americas Human Oocyte Cryopreservation Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 30. Americas Human Oocyte Cryopreservation Market Size by Country (2019-2024) & (US$ Million)
 Table 31. Americas Human Oocyte Cryopreservation Market Size by Country (2025-2030) & (US$ Million)
 Table 32. EMEA Human Oocyte Cryopreservation Market Size by Type (2019-2024) & (US$ Million)
 Table 33. EMEA Human Oocyte Cryopreservation Market Size by Type (2025-2030) & (US$ Million)
 Table 34. EMEA Human Oocyte Cryopreservation Market Size by Application (2019-2024) & (US$ Million)
 Table 35. EMEA Human Oocyte Cryopreservation Market Size by Application (2025-2030) & (US$ Million)
 Table 36. EMEA Human Oocyte Cryopreservation Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 37. EMEA Human Oocyte Cryopreservation Market Size by Region (2019-2024) & (US$ Million)
 Table 38. EMEA Human Oocyte Cryopreservation Market Size by Region (2025-2030) & (US$ Million)
 Table 39. China Human Oocyte Cryopreservation Market Size by Type (2019-2024) & (US$ Million)
 Table 40. China Human Oocyte Cryopreservation Market Size by Type (2025-2030) & (US$ Million)
 Table 41. China Human Oocyte Cryopreservation Market Size by Application (2019-2024) & (US$ Million)
 Table 42. China Human Oocyte Cryopreservation Market Size by Application (2025-2030) & (US$ Million)
 Table 43. APAC Human Oocyte Cryopreservation Market Size by Type (2019-2024) & (US$ Million)
 Table 44. APAC Human Oocyte Cryopreservation Market Size by Type (2025-2030) & (US$ Million)
 Table 45. APAC Human Oocyte Cryopreservation Market Size by Application (2019-2024) & (US$ Million)
 Table 46. APAC Human Oocyte Cryopreservation Market Size by Application (2025-2030) & (US$ Million)
 Table 47. APAC Human Oocyte Cryopreservation Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 48. APAC Human Oocyte Cryopreservation Market Size by Region (2025-2030) & (US$ Million)
 Table 49. APAC Human Oocyte Cryopreservation Market Size by Region (2025-2030) & (US$ Million)
 Table 50. Anova Fertility Company Details
 Table 51. Anova Fertility Business Overview
 Table 52. Anova Fertility Human Oocyte Cryopreservation Product
 Table 53. Anova Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 54. Anova Fertility Recent Development
 Table 55. CCRM IVF Company Details
 Table 56. CCRM IVF Business Overview
 Table 57. CCRM IVF Human Oocyte Cryopreservation Product
 Table 58. CCRM IVF Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 59. CCRM IVF Recent Development
 Table 60. Chill Company Details
 Table 61. Chill Business Overview
 Table 62. Chill Human Oocyte Cryopreservation Product
 Table 63. Chill Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 64. Chill Recent Development
 Table 65. CREATE Fertility Company Details
 Table 66. CREATE Fertility Business Overview
 Table 67. CREATE Fertility Human Oocyte Cryopreservation Product
 Table 68. CREATE Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 69. CREATE Fertility Recent Development
 Table 70. Extend Fertility Company Details
 Table 71. Extend Fertility Business Overview
 Table 72. Extend Fertility Human Oocyte Cryopreservation Product
 Table 73. Extend Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 74. Extend Fertility Recent Development
 Table 75. HRC Fertility Company Details
 Table 76. HRC Fertility Business Overview
 Table 77. HRC Fertility Human Oocyte Cryopreservation Product
 Table 78. HRC Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 79. HRC Fertility Recent Development
 Table 80. IVF Australia Company Details
 Table 81. IVF Australia Business Overview
 Table 82. IVF Australia Human Oocyte Cryopreservation Product
 Table 83. IVF Australia Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 84. IVF Australia Recent Development
 Table 85. Kindbody Company Details
 Table 86. Kindbody Business Overview
 Table 87. Kindbody Human Oocyte Cryopreservation Product
 Table 88. Kindbody Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 89. Kindbody Recent Development
 Table 90. London Women’s Clinic Company Details
 Table 91. London Women’s Clinic Business Overview
 Table 92. London Women’s Clinic Human Oocyte Cryopreservation Product
 Table 93. London Women’s Clinic Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 94. London Women’s Clinic Recent Development
 Table 95. Manchester Fertility Company Details
 Table 96. Manchester Fertility Business Overview
 Table 97. Manchester Fertility Human Oocyte Cryopreservation Product
 Table 98. Manchester Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 99. Manchester Fertility Recent Development
 Table 100. Mayo Clinic Company Details
 Table 101. Mayo Clinic Business Overview
 Table 102. Mayo Clinic Human Oocyte Cryopreservation Product
 Table 103. Mayo Clinic Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 104. Mayo Clinic Recent Development
 Table 105. Melbourne IVF Company Details
 Table 106. Melbourne IVF Business Overview
 Table 107. Melbourne IVF Human Oocyte Cryopreservation Product
 Table 108. Melbourne IVF Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 109. Melbourne IVF Recent Development
 Table 110. Monash IVF Company Details
 Table 111. Monash IVF Business Overview
 Table 112. Monash IVF Human Oocyte Cryopreservation Product
 Table 113. Monash IVF Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 114. Monash IVF Recent Development
 Table 115. Pacific Fertility Center-Los Angeles (PFCLA) Company Details
 Table 116. Pacific Fertility Center-Los Angeles (PFCLA) Business Overview
 Table 117. Pacific Fertility Center-Los Angeles (PFCLA) Human Oocyte Cryopreservation Product
 Table 118. Pacific Fertility Center-Los Angeles (PFCLA) Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 119. Pacific Fertility Center-Los Angeles (PFCLA) Recent Development
 Table 120. PIVET Company Details
 Table 121. PIVET Business Overview
 Table 122. PIVET Human Oocyte Cryopreservation Product
 Table 123. PIVET Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 124. PIVET Recent Development
 Table 125. Prelude Fertility Company Details
 Table 126. Prelude Fertility Business Overview
 Table 127. Prelude Fertility Human Oocyte Cryopreservation Product
 Table 128. Prelude Fertility Revenue in Human Oocyte Cryopreservation Business (2019-2024) & (US$ Million)
 Table 129. Prelude Fertility Recent Development
 Table 130. Research Programs/Design for This Report
 Table 131. Key Data Information from Secondary Sources
 Table 132. Key Data Information from Primary Sources


List of Figures
 Figure 1. Human Oocyte Cryopreservation Product Picture
 Figure 2. Global Human Oocyte Cryopreservation Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 3. Global Human Oocyte Cryopreservation Market Size 2019-2030 (US$ Million)
 Figure 4. China Human Oocyte Cryopreservation Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 5. China Human Oocyte Cryopreservation Market Size 2019-2030 (US$ Million)
 Figure 6. China Human Oocyte Cryopreservation Market Share in Global 2019-2030
 Figure 7. Human Oocyte Cryopreservation Report Years Considered
 Figure 8. Product Picture of Slow-cooling Method
 Figure 9. Product Picture of Flash-freezing Process (Vitrification)
 Figure 10. Global Human Oocyte Cryopreservation Market Share by Type in 2023 & 2030
 Figure 11. Global Human Oocyte Cryopreservation Market Size by Type (2019-2030) & (US$ Million)
 Figure 12. Global Human Oocyte Cryopreservation Market Share by Type (2019-2030)
 Figure 13. China Human Oocyte Cryopreservation Market Share by Type in 2023 & 2030
 Figure 14. China Human Oocyte Cryopreservation Market Size by Type (2019-2030) & (US$ Million)
 Figure 15. China Human Oocyte Cryopreservation Market Share by Type (2019-2030)
 Figure 16. Product Picture of 25-30 Year Old Female
 Figure 17. Product Picture of 30-35 Year Old Female
 Figure 18. Product Picture of 35-40 Year Old Female
 Figure 19. Product Picture of Others
 Figure 20. Global Human Oocyte Cryopreservation Market Share by Application in 2023 & 2030
 Figure 21. Global Human Oocyte Cryopreservation Market Size by Application (2019-2030) & (US$ Million)
 Figure 22. Global Human Oocyte Cryopreservation Market Share by Application (2019-2030)
 Figure 23. China Human Oocyte Cryopreservation Market Share by Application in 2023 & 2030
 Figure 24. China Human Oocyte Cryopreservation Market Size by Application (2019-2030) & (US$ Million)
 Figure 25. China Human Oocyte Cryopreservation Market Share by Application (2019-2030)
 Figure 26. The Top 5 and 10 Largest Companies of Human Oocyte Cryopreservation in the World: Market Share by Human Oocyte Cryopreservation Revenue in 2023
 Figure 27. Global Human Oocyte Cryopreservation Market Size Market Share by Region: 2019 VS 2023 VS 2030
 Figure 28. Global Human Oocyte Cryopreservation Market Share by Region (2019-2030)
 Figure 29. Americas Human Oocyte Cryopreservation Market Size Growth Rate 2019-2030 (US$ Million)
 Figure 30. Americas Human Oocyte Cryopreservation Market Share by Type (2019-2030)
 Figure 31. Americas Human Oocyte Cryopreservation Market Share by Application (2019-2030)
 Figure 32. United States Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Canada Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Mexico Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Brazil Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 36. EMEA Human Oocyte Cryopreservation Market Size Growth Rate 2019-2030 (US$ Million)
 Figure 37. EMEA Human Oocyte Cryopreservation Market Share by Type (2019-2030)
 Figure 38. EMEA Human Oocyte Cryopreservation Market Share by Application (2019-2030)
 Figure 39. Europe Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Middle East Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Africa Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Human Oocyte Cryopreservation Market Size Growth Rate 2019-2030 (US$ Million)
 Figure 43. China Human Oocyte Cryopreservation Market Share by Type (2019-2030)
 Figure 44. China Human Oocyte Cryopreservation Market Share by Application (2019-2030)
 Figure 45. APAC Human Oocyte Cryopreservation Market Size Growth Rate 2019-2030 (US$ Million)
 Figure 46. APAC Human Oocyte Cryopreservation Market Share by Type (2019-2030)
 Figure 47. APAC Human Oocyte Cryopreservation Market Share by Application (2019-2030)
 Figure 48. Japan Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 49. South Korea Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 50. China Taiwan Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 51. ASEAN Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 52. India Human Oocyte Cryopreservation Market Size Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Anova Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 54. CCRM IVF Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 55. Chill Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 56. CREATE Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 57. Extend Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 58. HRC Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 59. IVF Australia Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 60. Kindbody Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 61. London Women’s Clinic Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 62. Manchester Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 63. Mayo Clinic Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 64. Melbourne IVF Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 65. Monash IVF Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 66. Pacific Fertility Center-Los Angeles (PFCLA) Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 67. PIVET Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 68. Prelude Fertility Revenue Growth Rate in Human Oocyte Cryopreservation Business (2019-2024)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed

Description

The global Human Oocyte Cryopreservation revenue was US$ 82 million in 2023 and is forecast to a readjusted size of US$ 210 million by 2030 with a CAGR of 15.0% during the review period (2024-2030).

In China the Human Oocyte Cryopreservation revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and China Human Oocyte Cryopreservation market, also covers the segmentation data of other regions in regional level and county level.

Market Segmentation